project id: TCGA-ACC; case submitter id: TCGA-OR-A5LD; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.98; rna integrity number: 7.0; age at index: 52; days to birth: -19111; days to death: 1197; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1946; year of death: 2001; age at diagnosis: 19111; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 1998; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 5280; initial weight: 200.0; sample id: 5fe9fdb5-f6f9-40da-8cc8-413c4305e86a; sample submitter id: TCGA-OR-A5LD-01A; portion id: 45dc97f9-008e-43b2-99be-37dd1e98c96b; portion submitter id: TCGA-OR-A5LD-01A-11; slide id: c5103f20-e171-4670-b989-47d380003be0; slide submitter id: TCGA-OR-A5LD-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;